A Randomized Phase II Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
Status:
NOT_YET_RECRUITING
Trial end date:
2031-08-22
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to learn if the combination of cemiplimab and fianlimab can improve outcomes compared to cemiplimab alone in adults with Human Papillomavirus Positive HPV-positive head and neck cancer.